Bristol-Myers Squibb's aborted deal with generic drugmaker Apotex over the blood thinner Plavix led to a world of trouble for BMS. The pharmaceutical company has spent the last few years resolving Plavix-related cases. Most recently, it disclosed a deal to settle a securities class action for $125 million.

Though it's only filed eight complaints since first turning to the courts a year ago to enforce its massive patent portfolio, Intellectual Ventures has already tapped a varied roster of firms. On Thursday IV added Dechert to the list in a suit claiming that AT&T, Sprint, and T-Mobile infringe 15 patents related to wireless technology.

The Yetter, Warden & Coleman appellate litigator is a conservative star, so his position in the cases--both of which involve hot-button political issues--is no surprise. The timing, however, is.

Who killed Lehman? That's one of the most hotly debated questions of the Great Financial Meltdown of 2008. And now we know who's going to answer it: former Chicago U.S. Attorney Anton Valukas.

In a ruling that offers a broad interpretation of the protection afforded law firms by the Supreme Court's Stoneridge ruling, Manhattan federal judge Gerald Lynch has granted a motion by Mayer Brown and former partner Joseph Collins to dismiss Refco shareholder claims against them.

Philadelphia federal district court judge Gene Pratter proved once again that she can serve up a good egg joke. But it's a good bet the defendants aren't laughing.